Vesell E S, Penno M B
Clin Pharmacokinet. 1983 Sep-Oct;8(5):378-409. doi: 10.2165/00003088-198308050-00002.
The advantages and limitations of the 2 most commonly used methods to investigate interindividual pharmacokinetic variations are reviewed. The first method is based on pharmacokinetic comparisons made after repeated administration of a model drug such as antipyrine, before, during and after imposition of a carefully controlled environmental perturbation. A principal virtue of the test is the use of each subject as a control. Subjects are usually under near basal conditions with respect to factors capable of altering hepatic drug-metabolising capacity. Exceedingly sensitive, the test yields highly reproducible results. It has been useful as a research tool in identifying environmental factors for which dose-response curves can be generated and compared. However, the test requires careful selection and control of subjects, and it may be hazardous to extrapolate results to subjects under different, non-basal, environmental conditions. This method most frequently involves antipyrine as the test compound, but other drugs can and have been used. The results disclose that many host factors that influence antipyrine disposition also affect the disposition of other drugs metabolised by hepatic mixed-function oxidases. Recent refinement of the antipyrine test involves measurement of the rate constant for formation of each of the 3 main metabolites of antipyrine. Sensitivity and specificity of the test are increased through examination of the effect of each factor on a separate hepatic cytochrome P-450. Due to the labouriousness of this procedure and its requirement for several days of urine collection from each subject, metabolite analysis will probably remain an experimental method not applicable for screening populations. The second method involves a particular model based on multiple regression analysis. Relying on correlations with historical data of a qualitative nature, previous applications of this method have been retrospective, rather than prospective. Several such correlations could not be confirmed in normal subjects under the conditions of a controlled prospective experiment. Thus, prospective studies need to be performed to check results obtained with this method. The model used appears to enjoy certain advantages, including speed, simplicity, and ease of execution.(ABSTRACT TRUNCATED AT 400 WORDS)
本文综述了两种最常用的研究个体间药代动力学差异方法的优缺点。第一种方法是基于在反复给予模型药物(如安替比林)后,在精心控制的环境扰动之前、期间和之后进行药代动力学比较。该测试的一个主要优点是将每个受试者作为对照。受试者通常处于接近基础状态,不存在能够改变肝脏药物代谢能力的因素。该测试极其灵敏,能产生高度可重复的结果。它作为一种研究工具,有助于识别能够生成并比较剂量反应曲线的环境因素。然而,该测试需要仔细挑选和控制受试者,将结果外推至不同的、非基础环境条件下的受试者可能存在风险。此方法最常使用安替比林作为测试化合物,但也可以且已经使用其他药物。结果表明,许多影响安替比林处置的宿主因素也会影响其他经肝脏混合功能氧化酶代谢的药物的处置。安替比林测试的最新改进涉及测量安替比林三种主要代谢物各自形成的速率常数。通过检查每个因素对单独一种肝细胞色素P - 450的影响,提高了测试的灵敏度和特异性。由于该过程繁琐,且需要从每个受试者收集几天的尿液,代谢物分析可能仍将是一种不适用于人群筛查的实验方法。第二种方法涉及基于多元回归分析的特定模型。该方法依赖于与定性历史数据的相关性,以往的应用多为回顾性而非前瞻性的。在对照前瞻性实验条件下,正常受试者中无法证实若干此类相关性。因此,需要进行前瞻性研究以检验用此方法获得的结果。所使用的模型似乎具有某些优点,包括速度快、简单且易于实施。(摘要截取自400字)